N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA

被引:38
作者
Schnappauf, F
Hake, SB
Carvajal, MMC
Bontron, S
Lisowska-Grospierre, B
Steimle, V
机构
[1] Max Planck Inst Immunbiol, Hans Spemann Labs, Freiberg, Germany
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Univ Geneva, Dept Genet & Microbiol, Geneva, Switzerland
[4] Hop Necker Enfants Malad, Paris, France
关键词
MHC class II gene regulation; ubiquitin-proteasome system;
D O I
10.1002/eji.200323490
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Major histocompatibility complex (MHC) class II molecules play an essential role for the cellular immune response by presenting peptide antigens to CD4(+) T cells. MHC class II molecules and genes show a highly complex expression pattern, which is orchestrated through a master regulatory factor, called CIITA (class II transactivator). CIITA controls MHC class II expression not only qualitatively, but also quantitatively, and has therefore a direct influence on the CD4 T cell-dependent immune response. CIITA is itself tightly regulated not only on the transcriptional level, but as we show here also on the protein level. CIITA is subjected to a very rapid protein turnover and shows a half-life of about 30 min. Inhibition of degradation by proteasome inhibitors and the identification of ubiquitylated CIITA intermediates indicate that the degradation of CIITA is mediated by the ubiquitin-proteasome system. We identified two regions mediating degradation within the N-terminal domain of CIITA. N-terminal fusions or deletions stabilized CIITA, indicating that the N termini contribute to degradation. Several non-functional CIITA mutants are partially stabilized, but we provide evidence that transcriptional activity of CIITA is not directly linked to degradation.
引用
收藏
页码:2337 / 2347
页数:11
相关论文
共 43 条
  • [21] Masternak K, 2000, GENE DEV, V14, P1156
  • [22] Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo
    Molinari, E
    Gilman, M
    Natesan, S
    [J]. EMBO JOURNAL, 1999, 18 (22) : 6439 - 6447
  • [23] Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA
    MuhlethalerMOttet, A
    Otten, LA
    Steimle, V
    Mach, B
    [J]. EMBO JOURNAL, 1997, 16 (10) : 2851 - 2860
  • [24] Otten LA, 1998, EUR J IMMUNOL, V28, P473, DOI 10.1002/(SICI)1521-4141(199802)28:02<473::AID-IMMU473>3.0.CO
  • [25] 2-E
  • [26] Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/0968-0004(96)10031-1
  • [27] The bare lymphocyte syndrome and the regulation of MHC expression
    Reith, W
    Mach, B
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 : 331 - 373
  • [28] ACTIVATION OF CLASS-II MHC GENES REQUIRES BOTH THE X-BOX REGION AND THE CLASS-II TRANSACTIVATOR (CIITA)
    RILEY, JL
    WESTERHEIDE, SD
    PRICE, JA
    BROWN, JA
    BOSS, JM
    [J]. IMMUNITY, 1995, 2 (05) : 533 - 543
  • [29] XENOPUS-EMBRYOS REGULATE THE NUCLEAR-LOCALIZATION OF XMYOD
    RUPP, RAW
    SNIDER, L
    WEINTRAUB, H
    [J]. GENES & DEVELOPMENT, 1994, 8 (11) : 1311 - 1323
  • [30] Regulation of transcriptional activation domain function by ubiquitin
    Salghetti, SE
    Caudy, AA
    Chenoweth, JG
    Tansey, WP
    [J]. SCIENCE, 2001, 293 (5535) : 1651 - 1653